1 code implementation • 12 Mar 2024 • Gregory W. Kyro, Matthew T. Martin, Eric D. Watt, Victor S. Batista
The link between in vitro hERG ion channel inhibition and subsequent in vivo QT interval prolongation, a critical risk factor for the development of arrythmias such as Torsade de Pointes, is so well established that in vitro hERG activity alone is often sufficient to end the development of an otherwise promising drug candidate.
2 code implementations • 11 Sep 2023 • Gregory W. Kyro, Anton Morgunov, Rafael I. Brent, Victor S. Batista
We demonstrate the applicability of this methodology to targeted molecular generation by fine-tuning a GPT-based molecular generator toward a protein with FDA-approved small-molecule inhibitors, c-Abl kinase.
1 code implementation • 30 May 2023 • Anthony M. Smaldone, Gregory W. Kyro, Victor S. Batista
As the rapidly evolving field of machine learning continues to produce incredibly useful tools and models, the potential for quantum computing to provide speed up for machine learning algorithms is becoming increasingly desirable.
1 code implementation • 23 Dec 2022 • Gregory W. Kyro, Rafael I. Brent, Victor S. Batista
Applying deep learning concepts from image detection and graph theory has greatly advanced protein-ligand binding affinity prediction, a challenge with enormous ramifications for both drug discovery and protein engineering.